USD
+$0.00
(+0.00%
)At Close (As of Sep 12, 2025)
$16.12M
Market Cap
-
P/E Ratio
-0.84
EPS
$6.17
52 Week High
$2.68
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $3.8M |
Total Revenue | $11M |
Cost Of Revenue | $7.4M |
Costof Goods And Services Sold | $7.4M |
Operating Income | -$1.2M |
Selling General And Administrative | $5M |
Research And Development | $7.4M |
Operating Expenses | $12M |
Investment Income Net | - |
Net Interest Income | $1.1M |
Interest Income | $1.1M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $41K |
Income Before Tax | $9K |
Income Tax Expense | $681 |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $8.4K |
Comprehensive Income Net Of Tax | - |
Ebit | -$1.2M |
Ebitda | -$1.1M |
Net Income | $8.4K |
Field | Value (USD) |
---|---|
Total Assets | $23M |
Total Current Assets | $22M |
Cash And Cash Equivalents At Carrying Value | $6.2M |
Cash And Short Term Investments | $6.2M |
Inventory | - |
Current Net Receivables | $120K |
Total Non Current Assets | $189K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $15M |
Other Current Assets | $568K |
Other Non Current Assets | - |
Total Liabilities | $1.5M |
Total Current Liabilities | $1.5M |
Current Accounts Payable | $272K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $439K |
Total Non Current Liabilities | $0 |
Capital Lease Obligations | - |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $439K |
Other Current Liabilities | $483K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $21M |
Treasury Stock | - |
Retained Earnings | -$200M |
Common Stock | $8.9K |
Common Stock Shares Outstanding | $5.4M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$1.2M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $41K |
Capital Expenditures | $90K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $2.4M |
Cashflow From Financing | $209K |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $8.4K |
Field | Value (USD) |
---|---|
Gross Profit | $3.8M |
Total Revenue | $11M |
Cost Of Revenue | $7.4M |
Costof Goods And Services Sold | $7.4M |
Operating Income | -$1.2M |
Selling General And Administrative | $5M |
Research And Development | $7.4M |
Operating Expenses | $12M |
Investment Income Net | - |
Net Interest Income | $1.1M |
Interest Income | $1.1M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $41K |
Income Before Tax | $9K |
Income Tax Expense | $681 |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $8.4K |
Comprehensive Income Net Of Tax | - |
Ebit | -$1.2M |
Ebitda | -$1.1M |
Net Income | $8.4K |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah.